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FIGO CONSENSUS GUIDELINES ON 
INTRAPARTUM FETAL MONITORING 
Safe Motherhood and Newborn Health Committee 
Co-ordinator: Diogo Ayres-de-Campos 
 
 
 
INTERMITTENT AUSCULTATION 
Debrah Lewis, Soo Downe, for the FIGO intrapartum fetal monitoring consensus panel. 
 
Consensus panel: Daniel Surbek (Switzerland*), Gabriela Caracostea (Romania*), Yves Jacquemyn (Belgium*), 
Susana Santo (Portugal*), Lennart Nordström (Sweden*), Vladas Gintautas (Lithuania*), Tulia Todros (Italy*), 
Branka Yli (Norway*), George Farmakidis (Greece*), Sandor Valent (Hungary*), Bruno Carbonne (France*), Kati 
Ojala (Finland*), José Luis Bartha (Spain*), Joscha Reinhard (Germany*), Anneke Kwee (Netherlands*), Romano 
Byaruhanga (Uganda*), Ehigha Enabudoso (Nigeria*), John Anthony (South Africa*), Fadi Mirza (Lebanon*), Tak 
Yeung Leung (Hong Kong*), Ramon Reyles (Philippines*), Park In Yang (South Korea*), Henry Murray (Australia 
and New Zealand*), Yuen Tannirandorn  (Thailand*), Krishna Kumar (Malaysia*), Taghreed Alhaidary (Iraq*), 
Tomoaki Ikeda (Japan*), Ferdusi Begum (Bangladesh*), Mamoona Mushtaq (Pakistan*), Jorge Carvajal (Chile*), 
José Teppa (Venezuela*), Renato Sá (Brasil*), Lawrence Devoe (USA**), Gerard Visser (Netherlands**), Richard 
Paul (USA**), Barry Schifrin (USA**), Julian Parer (USA**), Philip Steer (UK**), Vincenzo Berghella (USA**), Isis 
Amer-Wahlin (Sweden**), Susanna Timonen (Finland**), Austin Ugwumadu (UK**), João Bernardes (Portugal**), 
Justo Alonso (Uruguay**), Sabaratnam Arulkumaran (UK**). 
 
* nominated by FIGO associated national society; ** invited by FIGO based on literature search 
 
The views expressed in this document reflect the opinion of the individuals and not necessarily of the institutions 
that they represent. 
 
 
INTRODUCTION 
Intermittent auscultation (IA) is defined as the technique of listening to the fetal heart rate 
(FHR) at intervals rather than continuously. Whether it be used for intrapartum fetal 
monitoring in low risk women or for all cases in settings where there are no available 
alternatives, all healthcare professionals attending labor and delivery need to be skilled at 
performing IA, interpreting its findings, and taking appropriate action. The main aim of 
this chapter is to describe the tools and techniques for IA in labor. 
 
HISTORICAL BACKGROUND 
Hippocrates is said to have described the technique of listening to the internal activity of 
the body by placing the ear on the skin proximal to the organ under examination. 
However, the perception of fetal heart sounds using this method was not reported until 
the 1600’s 1. Little notice appears to have been taken of this until 1818, when fetal heart 
auscultation was discussed by both Mayor and Kergaradec 2 , with the purpose of 
determining whether the fetus was alive or dead. Interest then accelerated, and, in 1833, 
Kennedy published a book on the subject of obstetric auscultation 3.  
The first recorded use of an amplification device for auscultation of the adult heart rate is 
attributed to Laënnac in 1816, who overcame the embarrassment of placing the ear on a 
young woman’s chest to hear her heart beat, by rolling sheets of paper into a tube and 
listening through this device. This tool was soon replicated in wood, and the technology 
was rapidly applied to fetal heart auscultation. The most common instrument currently 
used for this purpose is the Pinard stethoscope (Fig. 1 & 2). In some countries, notably 
the US, the DeLee stethoscope is used as an alternative (Fig. 3). In both cases, the 
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technology has not changed radically from the original design, in which a belled tube 
creates an amplification chamber for sound waves that are directly transmitted from the 
fetal heart to the examiner’s ear.  
 
More recently, instruments that rely on the Doppler effect, the Doptone (Fig. 4), have been 
used for IA, as well as for continuous CTG. However, as described in Chapter 3, these 
apparatuses do not transmit the actual sound produced by the fetal heart, but rather a 
simulation of this, based on ultrasound-detected movements of intracardiac structures, 
that are then subject to signal modification and autocorrelation.  
 
Table 1.  Advantages and disadvantages of instruments used for intermittent 
auscultation 
 
 
OBJECTIVES AND INDICATIONS 
As for other approaches to fetal monitoring, the main aim of IA is the timely identification 
of fetuses that are being inadequately oxygenated, to enable appropriate action before the 
occurrence of injury. It also allows the confirmation of adequate fetal oxygenation, so that 
unnecessary obstetric intervention can be avoided. Systematic reviews of randomised 
controlled trials carried out in the 1970s, 1980s and early 1990s, comparing IA with 
continuous cardiotocography (CTG) for intrapartum monitoring in both low- and high-risk 
women, showed that CTG is associated with a lower risk of neonatal seizures, but no 
difference in the incidence of overall perinatal mortality or cerebral palsy4.  Cesarean 
section and instrumental vaginal delivery rates were also higher in the CTG arm. The 
overall interpretation is that there is no conclusive evidence for the benefits of either 
continuous CTG or IA monitoring. (see Chapter 3).  
IA is frequently used for routine intrapartum monitoring in low-risk cases. It is also the 
option of choice in settings where there is either no access to CTG monitors or to the tools 
and resources necessary for using them.  
  
ADVANTAGES OF IA 
Performing regular IA ensures frequent contact between healthcare professionals and the 
laboring woman, offering the opportunity for social and clinical support. This optimizes 
the therapeutic benefits of interpersonal relationships5 and allows for assessment of other 
physical parameters, such as maternal skin tone and temperature, and breathing rates 
and patterns, and for direct palpation of fetal movements and of the strength of maternal 
contractions.  
IA also permits the fetal heart to be monitored in various positions and locations and 
favors the mobility of laboring women, which has been shown to benefit the progress of 
labor6. Another benefit of IA is the easier sustainability and availability of the technology, 
which allows it to be undertaken in even the lowest resource settings.  
 
 Advantages Disadvantages 
Pinard 
stethoscope 
Inexpensive 
Readily available in most countries 
No consumables needed  
May be difficult to use in 
certain maternal positions 
DeLee 
stethoscope 
Inexpensive 
Readily available in some countries 
No consumables needed  
May be difficult to use in 
certain maternal positions 
Doptone May be more comfortable for the woman 
FHR audible to all present in the room 
Can be used in various maternal 
positions and locations (e.g. in water) 
May calculate and display FHR values 
More costly  to purchase and 
maintain 
Requires batteries 
Probe is very sensitive to 
mechanical damage 
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DISADVANTAGES OF IA 
It takes time to develop clinical expertise with IA when performed with a fetal stethoscope. 
Initially it may not be easy to recognize the fetal heart sounds, and later on there is a slow 
learning curve for the identification of accelerations and the different types of 
decelerations. Even for the most experienced healthcare professionals, it is difficult to 
recognize subtle features of the FHR, such as variability. Sometimes awkward positions 
need to be adopted for effective auscultation, therefore healthcare professionals should 
ensure good ergonomic position for themselves and the laboring woman when using IA. 
There is usually no confirmation of the findings by other healthcare professionals, or by 
those in the room, and this may lead to uncertainty in medical-legal cases. 
 
Many of these disadvantages are overcome by the use of a handheld Doptone. When the 
latter includes a display showing the instantaneous FHR, even low variability may be 
identified if auscultation is prolonged for several minutes. 
 
Whichever method of IA is used, the need for regular personal attendance on laboring 
women can cause difficulty in busy labor units where there are few  appropriately trained 
staff.   
 
 
TECHNIQUE FOR PERFORMING IA 
Before IA is initiated, a clear explanation of the technique and its purpose should be 
provided to the laboring woman, and her consent obtained. This is followed by an 
assessment of the fetal position on abdominal palpation, and placement of the 
stethoscope/Doppler probe over the fetal back, as this is where the heart rate will be 
heard most clearly. At the same time as IA is performed, a hand is placed in the uterine 
fundus to determine the frequency and duration of uterine contractions. 
There are no studies comparing the effectiveness and safety of different auscultation 
intervals7. Therefore, recommendations for the scheduling of IA are based on expert 
opinion. While the existing evidence does not preclude other timings of IA, 
standardisation of procedures is important for planning of healthcare during labor and for 
medical-legal purposes. 
The most common practice recommendations for performing IA are considered in Table 2.   
 Features to evaluate 
What to register 
FHR  
 
 
 
Duration: at least 60 
seconds. 
Baseline (in bpm), presence or 
absence of accelerations and 
decelerations. 
If decelerations are present 
continue to monitor for at least 3 
contractions and register their 
type: early, variable, late, 
prolonged and repetitive (see 
Chapter 3 for more details). 
Timing: before, during and 
at least 30-60 seconds after 
a contraction. 
Interval: Every 15 minutes 
in the Active Phase of the 
1st stage of labor. 
              Every 5 minutes in 
the 2nd stage of labor. 
Uterine contractions At the same time as FHR 
auscultation 
Frequency and duration of 
uterine contractions. 
Maternal heart rate  Every 60 minutes. Register in bpm. 
Table 2. Current most common practice recommendations for IA, uterine contraction and 
maternal heart rate monitoring during labor. 
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All the features listed in Table 2 need to be recorded in dedicated labor charts, to provide 
an ongoing account of the fetal heart rate, and as a basis for sharing information between 
caregivers who may become involved in the process. 
 
TAKING APPROPRIATE ACTION 
If assessment of the parameters described in Table 2, and the general behavior of the 
mother, indicate the continuous wellbeing of both mother and baby, IA may continue to 
be the technique of choice for labor.   
 
Abnormal findings on IA are listed in Table 3. Sometimes, variable decelerations can 
occur due to the maternal supine position and resulting aorto-caval compression. 
Changing the maternal position may quickly revert the situation. However, if a rapid 
normalization does not ensue, or if other types of decelerations or baseline changes are 
detected, continuous CTG should be immediately started where available and with 
maternal consent. Other indications for a change to continuous CTG after IA has been 
commenced include situations where the fetal heart rate cannot be detected, or heard 
clearly with IA, appearance of fresh and/or thick meconium, or the occurrence of 
maternal health complications that might compromise the fetus. 
 
 
Baseline Below 110 bpm or above 160 bpm 
Decelerations Presence of repetitive, variable, late or prolonged  
Contractions More than 5 contractions in a 10 minute period 
Table 3. Abnormal findings on IA. 
 
Recent in-depth research has resulted in the creation of an evidence based approach to 
the use of IA, including a decision framework7. Figures 5 and 6 give the details.  
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